Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Methoprene-tolerant protein (Met) is the primary receptor for juvenile hormone (JH), a sesquiterpenoid that regulates essential aspects of insect development, metamorphosis, and reproduction (Jindra et al., 2013, Annual Review of Entomology). As a member of the basic helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) family of transcription factors, Met binds JH and subsequently interacts with the co-activator Taiman to regulate the transcription of JH-responsive genes, such as Krüppel homolog 1 (Charles et al., 2011, PNAS). This signaling pathway is critical for maintaining the insect in a juvenile state and preventing premature metamorphosis (Bitra et al., 2012, Journal of Biological Chemistry). Because the JH signaling pathway is unique to arthropods and absent in vertebrates, it serves as a highly specific target for insect growth regulators (IGRs) like methoprene and pyriproxyfen (PubChem). These compounds act as JH mimics, disrupting the life cycle of pests and disease vectors, such as mosquitoes and fleas, making them valuable tools in public health and agriculture (WHO, 2021). Metamorphosis disruption via this receptor prevents the emergence of reproductive adults, effectively controlling population growth of harmful species. The specificity of this receptor to insects minimizes the risk of direct toxicity to humans and other mammals, although environmental impacts on other arthropods remain a concern (EPA, 2010).
Juvenile hormone mimics act as agonists of the Methoprene-tolerant protein, binding to the receptor's PAS-B domain to induce the formation of a heterodimer with the Taiman co-activator; this complex then binds to juvenile hormone response elements (JHREs) to activate genes like Kr-h1, which inhibits metamorphosis and disrupts reproductive development (Jindra et al., 2015, Annual Review of Entomology; Wen et al., 2015, PNAS).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methoprene-tolerant protein (Juvenile hormone receptor) (Met).